Erythropoietin does not increase the frequency of thromboembolic events or hepatocellular carcinoma in hepatitis C patients treated with combination antiviral therapy

被引：0
|
作者：
Gallegos-Orozco, Juan F. [1 ]
Werner, Kristina T. [2 ]
Rosati, Marianne [2 ]
Byrne, Thomas J. [2 ]
Balan, Vijayan [2 ]
Vargas, Hugo E. [2 ]
Rakela, Jorge [2 ]
机构：
[1] Mayo Clin, Dept Internal Med, Phoenix, AZ USA
[2] Mayo Clin, Div Transplantat Med, Phoenix, AZ USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2008年 / 103卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：2161 / 2162
页数：2
相关论文
共 50 条
  • [41] Risk of Hepatocellular Carcinoma after Antiviral Therapy in Different Sets of Korean Patients with Chronic Hepatitis C
    Yi, Sanayouna
    Choi, Jonggi
    Shim, Ju Hyun
    Park, Jina
    An, Jihyun
    Lee, Danbi
    Kim, Kong Mo
    Lim, Young-Suk
    Lee, Han Chu
    Chung, Young-Hwa
    Lee, Yung Sang
    HEPATOLOGY, 2016, 64 : 681A - 681A
  • [42] Antiviral Therapy in Patients With Chronic Hepatitis C-related Hepatocellular Carcinoma Responding to Palliative Treatment
    Yu, Jung-Hwan
    Kim, Ja Kyung
    Lee, Kwan Sik
    Lee, Jung Il
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2018, 52 (06) : 557 - 562
  • [43] Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C
    Scherzer, T. -M.
    Reddy, K. R.
    Wrba, F.
    Hofer, H.
    Staufer, K.
    Steindl-Munda, P.
    Gangl, A.
    Ferenci, P.
    JOURNAL OF VIRAL HEPATITIS, 2008, 15 (09) : 659 - 665
  • [44] Effectiveness of antiviral combination therapy in elderly patients with chronic hepatitis C
    Orlova, L. S.
    Malov, Igor V.
    Zamatkina, L. F.
    Makarova, S. V.
    Dagvadorj, Ya
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 : S57 - S58
  • [45] Combination antiviral therapy in patients with chronic hepatitis C and cryoglobulinemia.
    Schmidt, WN
    Labrecque, DR
    Voigt, MD
    Stapleton, JT
    Rayhill, SC
    Wen, F
    Perino-Phillips, MJ
    Swift, JM
    Hershberger, JM
    Ippolito, LA
    Geraets, DL
    Schmid, SA
    HEPATOLOGY, 2001, 34 (04) : 421A - 421A
  • [46] Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?
    Jang, Byoung Kuk
    CLINICAL AND MOLECULAR HEPATOLOGY, 2016, 22 (03) : 336 - 338
  • [47] The increase of von Willebrand factor as a new predictor of response to combination antiviral therapy in patients with chronic hepatitis C
    Homoncik, M
    Formann, E
    Sieghart, W
    Ferenci, P
    Gangl, A
    Peck-Radosavjevic, M
    HEPATOLOGY, 2005, 42 (04) : 672A - 672A
  • [48] Direct-Acting Antiviral Therapy for Hepatitis C Virus in Patients with BCLC Stage B/C Hepatocellular Carcinoma
    Lee, Shou-Wu
    Chen, Li-Shu
    Yang, Sheng-Shun
    Huang, Yi-Hsiang
    Lee, Teng-Yu
    VIRUSES-BASEL, 2022, 14 (11):
  • [49] Risk of hepatocellular carcinoma recurrence in patients treated with direct acting antiviral therapy
    Kilsny, Shimaa
    Gomaa, Asmaa
    Sabry, Aliaa
    Moaz, Inas
    Ezzat, Sameera
    Elwaraky, Mohamed
    Badra, Gamal
    Waked, Imam
    JOURNAL OF HEPATOLOGY, 2020, 73 : S606 - S606
  • [50] The Impact of Direct-acting Antiviral Therapy for Hepatitis C on Hepatocellular Carcinoma Risk
    Feng Su
    George N. Ioannou
    Current Hepatology Reports, 2018, 17 (4) : 377 - 384
12345